Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2023-11-16 00:00:00 ET · period of report 2023-11-14 · accession 0001415889-23-015195 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-11-16 | 2023-11-14+ | HALO | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale+OE | $39.44 | -20.0K | 151.9K | -12% | -$788.7K |
| DM | 2023-11-16 | 2023-11-14+ | HALO | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $14.06 | +20.0K | 161.9K | +14% | +$281.3K |
| DM | 2023-11-16 | 2023-11-14+ | HALO | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $0.00 | -20.0K | 18.5K | -52% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-14 | S | D | 1,708 | $39.08 | 151,911 | D | — | — | (F2) Represents a weighted average sales price per share. These shares were sold at prices ranging from $38.75 to $39.62. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 2 | Common | Common Stock | 2023-11-14 | M | A | 1,708 | $16.78 | 153,619 | D | — | — | |
| 3 | Common | Common Stock | 2023-11-14 | S | D | 8,292 | $39.08 | 151,911 | D | — | — | (F2) Represents a weighted average sales price per share. These shares were sold at prices ranging from $38.75 to $39.62. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 4 | Common | Common Stock | 2023-11-14 | M | A | 8,292 | $13.81 | 160,203 | D | — | — | |
| 5 | Common | Common Stock | 2023-11-15 | S | D | 10,000 | $39.79 | 151,911 | D | — | — | (F3) Represents a weighted average sales price per share. These shares were sold at prices ranging from $39.335 to $40.155. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 6 | Common | Common Stock | 2023-11-15 | M | A | 10,000 | $13.81 | 161,911 | D | — | — | |
| 7 | Derivative | Option to Purchase Common Stock | 2023-11-14 | M | D | 1,708 | $0.00 | 292 | D | $16.78 · — to 2028-07-02 | 1,708 Common Stock | (F5) This option was granted on July 2, 2018 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter. |
| 8 | Derivative | Option to Purchase Common Stock | 2023-11-15 | M | D | 10,000 | $0.00 | 8,533 | D | $13.81 · — to 2025-02-04 | 10,000 Common Stock | (F4) This option was granted on February 4, 2015 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter. |
| 9 | Derivative | Option to Purchase Common Stock | 2023-11-14 | M | D | 8,292 | $0.00 | 18,533 | D | $13.81 · — to 2025-02-04 | 8,292 Common Stock | (F4) This option was granted on February 4, 2015 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter. |